Reducing Nausea and Vomiting in Patient-Related Chemotherapy
Not Applicable
- Conditions
- Chemotherapy Induced Nausea and Vomiting.Malignant (primary) neoplasm, unspecifiedC80.1
- Registration Number
- IRCT20231027059871N1
- Lead Sponsor
- niversity of Baghdad/ College of Nursing
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Adult patients aged 18 and above diagnosed with cancer and undergoing chemotherapy
Read and write
Patients experiencing nausea and vomiting
Have no problems communicating
Fully conscious.
Exclusion Criteria
Skin ulcer
Patients with a history of psychiatric disorders
Respiratory diseases like asthma
Patients with a history of allergy to massage oil or aromatherapy
Patients who have problems communicating and are unconscious
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea and Vomiting-related Chemotherapy. Timepoint: After 24 hours from intervention. Method of measurement: Rhodes Index Scale Rhodes index of nausea, vomiting and retching (24 hours after chemotherapy).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie aromatherapy's antiemetic effects in chemotherapy-induced nausea?
How does massage therapy compare to standard antiemetics like ondansetron in managing CINV?
Are there biomarkers predicting response to non-pharmacological interventions for CINV in oncology?
What adverse events are associated with aromatherapy using lavender or peppermint oils in cancer patients?
How do combination approaches of massage and pharmacological agents improve CINV management?